Corporate Finance

Regulatory delays in China scuttled Pulmatrix's merger with Cullgen, forcing the biotech to urgently seek new partners for its promising drug pipeline.

On its 13th anniversary, MOCO Connectors launched a new 8,000sqm facility in Zhongshan, scaling up custom connector production for global high-tech markets.

A new supplement, backed by a gold-standard clinical trial, promises the metabolic and appetite-curbing benefits of fasting without any dietary changes.

HYCU earns its sixth straight CRN 5-Star award, signaling market dominance through its partner-first strategy and expansive R-Cloud SaaS support.

Ramen's new AI assistant slashes development from weeks to hours with autonomous agents, advanced animation tools, and breakthrough backend integration.

The infant nutrition giant is entering Canada's booming organic market, betting on brand trust to compete in an increasingly crowded and conscious space.

With a $41M boost from a16z, Ease Health is using AI to unify a fractured behavioral health system, promising relief for overwhelmed providers.

Donors granted a record $3.9 billion via Vanguard Charitable in 2025, highlighting the growing power and agility of donor-advised funds in philanthropy.

Avenacy launches its 26th product, a generic Benadryl injection, tackling drug shortages and aiming to improve patient safety with unique packaging.

With a $6B M&A war chest and a new AI focus, Roper Technologies takes the stage at Morgan Stanley. Here’s what investors will be watching for.

Total Joint Orthopedics surpasses 50,000 implants, signaling a major shift as surgeries move from hospitals to efficient, cost-effective surgery centers.

As its Reliquias mine restart nears, Silver Mountain launches a major drill campaign at Caudalosa, aiming to capitalize on a bullish silver market.

Fidelis Insurance Group completes a $163M repurchase of all shares from founding investor CVC, a move set to boost shareholder value ahead of its rebrand.

Leaders at PDAC 2026 forge a national strategy linking small modular reactors with critical minerals to secure Canada's energy and economic future.

Asia's largest pharma show returns, showcasing China's evolution from the world's factory to a global hub of drug innovation and supply chain strategy.

The healthcare firm reports a 56% revenue surge to $3.2B, but a "material weakness" in financial controls and a delayed SEC filing cast a shadow.

A new partnership between Japan's Marubeni and US firm Branford Castle promises to reshape the lower middle-market, offering small businesses global reach.

As childhood nearsightedness soars, a new contact lens offers hope by not just correcting vision but actively slowing its progression in key global markets.

With strong leasing, strategic sales, and new developments, BXP is proving that a 'flight to quality' can defy the broader office market downturn.

As AI-driven fraud skyrockets, the Canadian Bankers Association is arming citizens with new resources to spot scams and protect their finances.